Age, Biography and Wiki

Keiichi Itakura was born on 18 February, 1942 in Japan, is an A japanese molecular biologists. Discover Keiichi Itakura's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 82 years old?

Popular As N/A
Occupation N/A
Age 82 years old
Zodiac Sign Aquarius
Born 18 February 1942
Birthday 18 February
Birthplace N/A
Nationality Japan

We recommend you to check the complete list of Famous People born on 18 February. He is a member of famous with the age 82 years old group.

Keiichi Itakura Height, Weight & Measurements

At 82 years old, Keiichi Itakura height not available right now. We will update Keiichi Itakura's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.

Family
Parents Not Available
Wife Not Available
Sibling Not Available
Children Not Available

Keiichi Itakura Net Worth

His net worth has been growing significantly in 2023-2024. So, how much is Keiichi Itakura worth at the age of 82 years old? Keiichi Itakura’s income source is mostly from being a successful . He is from Japan. We have estimated Keiichi Itakura's net worth, money, salary, income, and assets.

Net Worth in 2024 $1 Million - $5 Million
Salary in 2024 Under Review
Net Worth in 2023 Pending
Salary in 2023 Under Review
House Not Available
Cars Not Available
Source of Income

Keiichi Itakura Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia
Imdb

Timeline

Keiichi Itakura (板倉 啓壹) is an organic chemist and a Professor in the Department of Molecular and Cellular Biology at the Beckman Research Institute at City of Hope National Medical Center.

1942

Itakura was born in Tokyo, Japan on February 18, 1942.

1970

He obtained a PhD in Organic Chemistry at Tokyo Pharmaceutical College in 1970.

He then accepted a fellowship with Saran A. Narang at the Division of Biological Sciences, National Research Council of Canada, to work on DNA synthesis.

1975

In 1975, Itakura joined the City of Hope National Medical Center.

There he was part of a team of scientists including Arthur Riggs who developed recombinant DNA technology.

1976

By 1976, the first artificial gene had been synthesized, by Har Gobind Khorana at MIT, and the possibility of synthesizing insulin through bacterial fermentation by incorporating a gene for insulin into a bacterium such as E. coli had been suggested.

Itakura and others succeeded in synthesizing a plasmid containing chemically synthesized lac operator in 1976, using a technique they called "linker technology".

""We used the technology that Itakura was the master of to make small pieces of DNA, which greatly improved the ability to cut and splice exactly where you wanted.

We devised how you can put them exactly where you want them... That was a major contribution." Arthur Riggs"

1977

In 1977, Itakura successfully synthesized the gene for somatostatin.

Production of somatostatin, a hormone produced in the human brain, was not expected to be commercially significant.

However, the work was considered a possible first step towards the creation of a synthetic insulin.

Building on Khorana's work, Itakura developed a technique that reduced the time involved in successful synthesis from years to weeks.

He then inserted the gene for somatostatin into E. coli.

This was the first demonstration of a foreign gene inserted into E. coli.

1978

By 1978 Herbert Boyer's biotechnology startup Genentech had contracted with Riggs and Itakura, and Boyer and Itakura had created a plasmid coded for human insulin.

Genentech signed a joint-venture agreement with Eli Lilly and Company to develop and market the technology.

1980

Keiichi Itakura became a senior research scientist at City of Hope in 1980.

1982

Their product, Humulin, approved in 1982 by the FDA, was the first biotechnology product to be marketed.

Genentech patented techniques that list Itakura and Riggs as the inventors, and are known as the Riggs-Itakura patents.

As their principal organic chemist, Keiichi Itakura was essential to the success of Genentech's development of synthetic insulin.

His work on recombinant DNA technology has had a significant impact in molecular biology and biochemistry.

In 1982, he formed the Department of Molecular Genetics (later the Department of Molecular and Cellular Biology).

1989

Itakura became director of City of Hope's genetics laboratory in 1989.

he continues to work and teach at City of Hope.